Results 21 to 30 of about 288,723 (312)
Propensity score matching method evaluate the clinical efficacy of comprehensive treatment for synchronous primary advanced gastric and esophageal cancer [PDF]
Waike lilun yu shijian, 2023 Objective To evaluate the clinical efficacy of comprehensive treatment for synchronous primary advanced gastric and esophageal cancer by propensity score matching (PSM).
ZHANG Peichan, LUO Chunyang, WU Wenya, WU Zhenfeng, CAO Qinhong, CHEN Che, WU Xiaoyu, YAO Xuequan, LIU Fukun
doaj +1 more source
Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori. [PDF]
, 2018 New Zealand Māori have a considerably higher incidence of gastric cancer compared to non-Māori, and are one of the few populations worldwide with a higher prevalence of diffuse-type disease.
Cheng, Soo +10 more
core +1 more source
Advanced Gastric Cancer in a Young Patient [PDF]
, 2003 Gastric cancer remains the second most common cancer in the world, and is usually found in men, especially those over 50 years of age. The diagnosis is made by endoscopic biopsy.
Abdullah, M. (Murdani) +4 more
core +1 more source
Advanced gastric cancer: Current treatment landscape and future perspectives. [PDF]
, 2016 Gastric cancer currently ranks fourth in cancer-related mortality worldwide. In the western world, it is most often diagnosed at an advanced stage, after becoming metastatic at distant sites. Patients with advanced disease (locally advanced or metastatic)
Digklia, A., Wagner, A.D.
core +1 more source
Biomarkers of Gastric Cancer: Current Advancement
SSRN Electronic Journal, 2022 Gastric cancer (GC) is one of the most prevalent malignant types worldwide, especially in East Asia. Due to its frequently advanced stage at diagnosis, the mortality from GC is high and the prognosis is still unsatisfactory. Thus, early detection using effective screening approaches is vital to decrease the morbidity and mortality of GC. Interestingly,
Tiantian Jiang +5 more
openaire +3 more sources
Emerging Therapies in the Management of Advanced-Stage Gastric Cancer
Frontiers in Pharmacology, 2018 Globally, gastric malignancy contributes to significant cancer-related morbidity and mortality. Despite a recent approval of two targeted agents, trastuzumab and ramucirumab, the treatment options for advanced-stage gastric cancer are limited ...
Vivek Kumar +4 more
doaj +1 more source
Stomach One-Point Cancer: One Case Report and Literature Review [PDF]
, 2009 Gastric cancer is one of the most common cancers and one of themost frequent causes of cancer deaths worldwide. Early detection andaccurate preoperative staging of gastric cancer is essential for planning optimal therapy such as endoscopic mucosal ...
B.Y. Zhao +8 more
core +2 more sources
Molecular Therapy: Oncolytics, 2020 Advanced gastric cancer, especially scirrhous gastric cancer with peritoneal dissemination, remains refractory to conventional therapies. G47Δ, a third-generation oncolytic herpes simplex virus type 1, is an attractive novel therapeutic agent for solid ...
Kotaro Sugawara +6 more
doaj +1 more source
Frontiers in Medicine, 2021 Gastric cancer is one of the most common cause of cancer related deaths worldwide which results in malignant tumors in the digestive tract. The only radical treatment option available is surgical resection.
Zhi-da Chen +5 more
doaj +1 more source
Advances in gastric cancer prevention
World Journal of Clinical Oncology, 2012 Gastric cancer is a multifactorial neoplastic pathology numbering among its causes both environmental and genetic predisposing factors. It is mainly diffused in South America and South-East Asia, where it shows the highest morbility percentages and it is relatively scarcely diffused in Western countries and North America.
GIORDANO, ANTONIO, Cito L.
openaire +4 more sources